New cholesterol drugs

More health news you should know about. An experimental class of cholesterol-lowering drugs is showing a lot of promise for up to 70 million Americans suffering from heart-related diseases and could generate $3 billion in annual sales for the companies racing to get those new medications on the market.

This entry was posted in Biotech & Pharmaceuticals, Health Care, NBR Show Clips. Bookmark the permalink.

Leave a Reply